Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1976
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1988 1
2018 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping Review.
Tran KA, Harrod C, Bourdette DN, Cohen DM, Deodhar AA, Hartung DM. Tran KA, et al. JAMA Intern Med. 2022 Feb 1;182(2):206-217. doi: 10.1001/jamainternmed.2021.7171. JAMA Intern Med. 2022. PMID: 34902005 Review.
Search terms included HP Acthar, ACTH gel, repository corticotropin, and terms for specific diseases, such as multiple sclerosis, nephrotic syndrome, rheumatoid arthritis, and West syndrome (or spasms, infantile). The review included randomized clinical trials (RCTs …
Search terms included HP Acthar, ACTH gel, repository corticotropin, and terms for specific diseases, such as multiple sclerosis, nephrotic …
Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.
Smith MT, McCrae CS, Cheung J, Martin JL, Harrod CG, Heald JL, Carden KA. Smith MT, et al. J Clin Sleep Med. 2018 Jul 15;14(7):1209-1230. doi: 10.5664/jcsm.7228. J Clin Sleep Med. 2018. PMID: 29991438 Free PMC article.
These data demonstrate that actigraphy provides consistent objective data that is often unique from patient-reported sleep logs for some sleep parameters in adult and pediatric patients with suspected or diagnosed insomnia, circadian rhythm sleep-wake disorders, sleep-disordered …
These data demonstrate that actigraphy provides consistent objective data that is often unique from patient-reported sleep logs for some sle …
Verification of the fetal valproate syndrome phenotype.
Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingstone S, Flannery DB, Pellock JM, Harrod MJ, Lammer EJ, et al. Ardinger HH, et al. Am J Med Genet. 1988 Jan;29(1):171-85. doi: 10.1002/ajmg.1320290123. Am J Med Genet. 1988. PMID: 3125743 Review.
We have evaluated 19 children who were exposed to valproic acid (VPA) in utero to look for manifestations of a fetal valproate syndrome (FVS), as proposed by Di Liberti et al. [1984]. We found no consistent alterations of pre- or postnatal growth with exposure to VPA monot …
We have evaluated 19 children who were exposed to valproic acid (VPA) in utero to look for manifestations of a fetal valproate syndrome